MAPT and Parkinson disease: When taken as single markers, CSF Aβ42, CSF total tau and caudate [123I]FP-CIT uptake are inadequate to identify PD patients at higher risk of cognitive decline, but taken together, these measures are able to predict cognitive decline in 65% of the cases.